$OKTA

Schwartz Larissa sold $296K of OKTA

Schwartz Larissa (See Remarks) sold 2,463 shares of Okta, Inc. (OKTA) at $120.00 ($0.30M total) on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Schwartz Larissa
Published Jun 24, 2026, 9:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 9:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OKTA
Neutral
medium confidence
Mentioned
$OKTA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKTANeutralLow
01

Why it matters

The newest fact is the specific sale: 2,463 shares at $120/share totaling $295,560, executed 2026-06-22 under a 10b5-1 plan. This is primarily a sentiment datapoint rather than a fundamental change.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no new guidance, deal, or regulatory development in the text.

03

What to watch

The filing does not disclose reasons for the sale beyond the plan; traders should avoid over-weighting insider selling absent corroborating fundamental news.

Relevance 3/10Novelty 3/10Timing: after-hours/filing update (Form 4 filed 2026-06-24)

Background

The article is an SEC Form 4 insider transaction disclosure for Okta, Inc. (OKTA).

Company-level read

Ticker impact

$OKTANeutralMedium confidence
Context

Okta insider Schwartz Larissa sold 2,463 shares on 2026-06-22 at $120/share under a pre-arranged 10b5-1 plan, per Form 4.

Expected impact

Low likelihood of a sustained price move solely from this disclosure; any impact is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan, which typically reduces interpretive value versus discretionary selling. The article contains no accompanying operational, financial, or regulatory catalyst.

Market effects

Minimal; single-company insider sale without sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity/compensation mechanics rather than bearish expectations.

Key entities

  • Okta, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Schwartz Larissa

    Officer who sold 2,463 shares under a pre-arranged 10b5-1 plan.

  • 10b5-1 plan

    Pre-arranged plan that typically reduces interpretive value of insider sales.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MRVLMed

Friday's Stocks to Watch

Marvell Technology (MRVL) reported non-GAAP EPS of $0.94 and 37% Y/Y revenue growth. Autodesk (ADSK) posted $3.30 EPS and 16.5% Y/Y revenue growth, but its MaintainX acquisition may slow profit growth. Workday (WDAY) reported $2.75 EPS and 12.8% Y/Y revenue growth. Okta (OKTA) gained 28.63% after completing its Permiso acquisition.

$OKTAMedAI 8/10

Okta Stock Just Got a New Street-High Price Target

Okta (OKTA) stock surged 28.63% post-earnings, reaching a 52-week high. Q2 revenue grew 11% YoY to $805M, with non-GAAP EPS at $1.05. Needham raised its price target to $200, the highest on Wall Street. Analysts anticipate 12% EPS growth in FY2027. The stock trades at 98.24x forward P/E.